

NCT02396420 comparison:

Summary:
CHIA has 26 criteria while your personal folder has 26 criteria
Total found criteria: 26/26
Total not Found: 0/26
Total Extra: 3
This trial is VALID



╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╕
│ CHIA Criteria                                      │ Matching Personal Criteria                         │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╡
│ Patient has provided signed informed consent       │ Patient has provided signed informed consent       │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patient is aged greater than or equal to 40 and    │ Patient is aged greater than or equal to 40 and    │
│ less than or equal to 89 years of age              │ less than or equal to 89 years of age              │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patient has a prostate size between 90g and 200g,  │ Patient has a prostate size between 90g and 200g,  │
│ as determined by MRI                               │ as determined by MRI                               │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patient has experienced lower urinary tract        │ Patient has experienced lower urinary tract        │
│ symptoms (LUTS) for at least 6 months prior to     │ symptoms (LUTS) for at least 6 months prior to     │
│ study enrollment                                   │ study enrollment                                   │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patient has an IPSS score of at least 13 at        │ Patient has an IPSS score of at least 13 at        │
│ baseline                                           │ baseline                                           │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patient is either: refractory to medical           │ Patient is either: refractory to medical           │
│ treatment, contraindicated to medical treatment,   │ treatment, contraindicated to medical treatment,   │
│ OR refuses medical treatment                       │ OR refuses medical treatment                       │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patient either: refuses surgical treatment OR is   │ Patient either: refuses surgical treatment OR is   │
│ contraindicated for surgical treatment             │ contraindicated for surgical treatment             │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patient meets ONE of the following criteria:       │ Patient meets ONE of the following criteria:       │
│ baseline PSA < 4.0ng/mL (no prostate biopsy        │ baseline PSA \< 4.0ng/mL (no prostate biopsy       │
│ required) OR baseline PSA >/= 4 ng/mL AND a        │ required) OR baseline PSA \>/= 4 ng/mL AND a       │
│ negative prostate biopsy (minimum 12 core biopsy)  │ negative prostate biopsy (minimum 12 core biopsy)  │
│ within the prior 12 months                         │ within the prior 12 months                         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ History of prostate, bladder, or rectal cancer     │ History of prostate, bladder, or rectal cancer     │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ History of transurethral resection of the prostate │ History of transurethral resection of the prostate │
│ (TURP), open prostate surgery, or radiofrequency   │ (TURP), open prostate surgery, or radiofrequency   │
│ or microwave therapies                             │ or microwave therapies                             │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ History of open bladder, rectosigmoid colon, or    │ History of open bladder, rectosigmoid colon, or    │
│ other pelvic surgery                               │ other pelvic surgery                               │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patient is unwilling to discontinue alpha blockers │ Patient is unwilling to discontinue alpha blockers │
│ 1 month after study treatment                      │ 1 month after study treatment                      │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patient is unwilling to discontinue 5-alph         │ Patient is unwilling to discontinue 5-alph         │
│ reductase inhibitors 1 month after study treatment │ reductase inhibitors 1 month after study treatment │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Neurogenic bladder or other neurologic disorder    │ Neurogenic bladder or other neurologic disorder    │
│ impacting bladder function such as Parkinson's     │ impacting bladder function such as Parkinson's     │
│ disease, multiple sclerosis, cerebral vascular     │ disease, multiple sclerosis, cerebral vascular     │
│ accident or diabetes                               │ accident or diabetes                               │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Any other confounding bladder or urethral          │ Any other confounding bladder or urethral          │
│ pathology, including urethral stricture, bladder   │ pathology, including urethral stricture, bladder   │
│ neck contracture, or bladder atonia                │ neck contracture, or bladder atonia                │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Active prostatitis or urinary tract infection      │ Active prostatitis or urinary tract infection      │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Cystolithiasis within the past 3 months            │ Cystolithiasis within the past 3 months            │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Serum creatinine > 1.7mg/dL                        │ Serum creatinine \> 1.7mg/dL                       │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Inability to discontinue oral anticoagulant 2-5    │ Inability to discontinue oral anticoagulant 2-5    │
│ days prior to study treatment                      │ days prior to study treatment                      │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Coagulation disturbances not normalized by medical │ Coagulation disturbances not normalized by medical │
│ treatment                                          │ treatment                                          │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Iodinated contrast allergy that, in the opinion of │ Iodinated contrast allergy that, in the opinion of │
│ the Investigator, cannot be adequately             │ the Investigator, cannot be adequately             │
│ premedicated                                       │ premedicated                                       │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Gelatin allergy                                    │ Gelatin allergy                                    │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Known severe peripheral vascular disease or major  │ Known severe peripheral vascular disease or major  │
│ iliac arterial occlusive disease                   │ iliac arterial occlusive disease                   │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Interest in future fertility                       │ Interest in future fertility                       │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Clinically significant cardiac arrhythmia or other │ Clinically significant cardiac arrhythmia or other │
│ cardiac disease (including congestive heart        │ cardiac disease (including congestive heart        │
│ failure), uncontrolled diabetes mellitus,          │ failure), uncontrolled diabetes mellitus,          │
│ clinically significant respiratory disease, or     │ clinically significant respiratory disease, or     │
│ known immunosuppression                            │ known immunosuppression                            │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Other condition that the Investigator believes     │ Other condition that the Investigator believes     │
│ puts the patient at risk for a complication during │ puts the patient at risk for a complication during │
│ the procedure                                      │ the procedure                                      │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╛



Everything was Found



╒═══════════════════════════════════╕
│ Extra Personal Criteria           │
╞═══════════════════════════════════╡
│ Must have minimum age of 40 Years │
├───────────────────────────────────┤
│ Must have maximum age of 89 Years │
├───────────────────────────────────┤
│ Must be MALE                      │
╘═══════════════════════════════════╛